Eli Lilly

Quitting Lilly's obesity drug tirzepatide may be difficult for many patients, exec says
Fierce Pharma
Thu, 04/27/23 - 10:48 pm
Eli Lilly
obesity
tirzepatide
patients
After gathering enough Nektar, Lilly hands back rights to immunology med post-lupus fail
Fierce Biotech
Thu, 04/27/23 - 11:48 am
Eli Lilly
Nektar Therapeutics
Rezpeg
lupus
Lilly drug Mounjaro succeeds in second weight loss study
BioPharma Dive
Thu, 04/27/23 - 11:43 am
Eli Lilly
obesity
Mounjaro
clinical trials
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
AbbVie
Amgen
Bristol Myers Squibb
Eli Lilly
Gilead Sceinces
JNJ
Merck
Pfizer
Regeneron
patents
activists
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
CNBC
Wed, 04/26/23 - 09:59 am
Biogen
earnings
Pharma CEOs
Chris Viehbacher
Eli Lilly
Alzheimer's disease
Leqembi
donanemab
See you later, Baqsimi: Lilly sells low blood sugar rescue treatment to Amphastar for $500M-plus
Fierce Pharma
Mon, 04/24/23 - 10:29 am
Eli Lilly
Baqsimi
Amphastar
hypoglycemia
diabetes
In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy
Fierce Pharma
Mon, 04/24/23 - 10:20 am
Eli Lilly
clinical trials
obesity
Mounjaro
Novo Nordisk
Wegovy
Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs
Reuters
Fri, 04/21/23 - 10:24 am
Eli Lilly
Medicare
Alzheimer's disease
Leqembi
What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take
Fierce Pharma
Fri, 04/21/23 - 10:22 am
Novo Nordisk
Eli Lilly
Sanofi
insulin
diabetes
drug prices
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'
Fierce Biotech
Tue, 04/18/23 - 10:18 pm
Eli Lilly
Amgen
Mirati Therapeutics
KRAS inhibitors
AACR
Lilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities
PR Newswire
Mon, 04/17/23 - 10:52 pm
Eli Lilly
drug manufacturing
Indiana
FDA declines to approve Eli Lilly's bowel disease drug
Yahoo/Reuters
Thu, 04/13/23 - 10:19 pm
Eli Lilly
IBD
FDA
mirikizumab
Bernie Sanders weighs Senate hearing for largest insulin makers
Seeking Alpha
Thu, 04/13/23 - 11:53 am
Bernie Sanders
diabetes
insulin
drug pricing
Eli Lilly
Sanofi
Novo Nordisk
Senate
Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes
Xtalks
Fri, 04/7/23 - 01:43 pm
Eli Lilly
Mounjaro
DTC ads
television ads
diabetes
Diabesity drugs and their free ‘contract sales force’
Medical Marketing and Media
Tue, 04/4/23 - 10:12 am
Novo Nordisk
Eli Lilly
diabetes
obesity
telehealth
social media
Mounjaro
Wegovy
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Lilly says experimental Alzheimer's drug reduces amyloid in small study
Reuters
Mon, 04/3/23 - 09:54 am
Eli Lilly
Alzheimer's disease
clinical trials
remternetug

Pages